ENTRY       D10176                      Drug
NAME        Trametinib dimethyl sulfoxide (JAN/USAN);
            Mekinist (TN)
PRODUCT     MEKINIST (Novartis Pharmaceuticals Corporation)
FORMULA     C26H23FIN5O4. C2H6OS
EXACT_MASS  693.0918
MOL_WEIGHT  693.5282
CLASS       Antineoplastic
             DG03137  MEK inhibitor
REMARK      Therapeutic category: 4291
            ATC code: L01EE01
            Chemical structure group: DG00723
            Product (DG00723): D10176<JP/US>
EFFICACY    Antineoplastic, Mitogen-activated extracellular signal-regulated kinase (MEK) inhibitor
  DISEASE   Melanoma (BRAF mutation positive) [DS:H00038]
            Non-small cell lung cancer (BRAF mutation positive) [DS:H00014]
            Anaplastic thyroid cancer (BRAF mutation positive) [DS:H00032]
TARGET      MAP2K1 (MEK1) [HSA:5604] [KO:K04368]
            MAP2K2 (MEK2) [HSA:5605] [KO:K04369]
  PATHWAY   hsa04010(5604+5605)  MAPK signaling pathway
            hsa04012(5604+5605)  ErbB signaling pathway
            hsa05200(5604+5605)  Pathways in cancer
            hsa05218(5604+5605)  Melanoma
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01E PROTEIN KINASE INHIBITORS
                L01EE Mitogen-activated protein kinase (MEK) inhibitors
                 L01EE01 Trametinib
                  D10176  Trametinib dimethyl sulfoxide (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Molecular Target Inhibitors
               Trametinib
                D10176  Trametinib dimethyl sulfoxide (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D10176  Trametinib dimethyl sulfoxide (JAN/USAN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG03137  MEK inhibitor
               DG00723  Trametinib
                D10176  Trametinib dimethyl sulfoxide
            Drug classes [BR:br08332]
             Antineoplastic
              DG03137  MEK inhibitor
               D10176  Trametinib dimethyl sulfoxide
            Target-based classification of drugs [BR:br08310]
             Protein kinases
              Serine/threonine kinases
               STE group
                MAP2K1 (MEK1)
                 D10176  Trametinib dimethyl sulfoxide (JAN/USAN) &lt;JP/US&gt;
                MAP2K2 (MEK2)
                 D10176  Trametinib dimethyl sulfoxide (JAN/USAN) &lt;JP/US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10176
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D10176
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D10176
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10176
            Pharmacogenomic biomarkers [br08341.html]
             Somatic variations in targeted cancer therapies
              D10176
            Drug groups [BR:br08330]
             Antineoplastic
              DG03137  MEK inhibitor
               DG00723  Trametinib
DBLINKS     CAS: 1187431-43-1
            PubChem: 135626894
            ChEBI: 75991
            LigandBox: D10176
ATOM        41
            1   C8y C    23.1000  -23.8000
            2   C8y C    23.1000  -25.1300
            3   C8y C    24.2200  -25.8300
            4   N4y N    25.4100  -25.1300
            5   C8y C    25.4100  -23.8000
            6   C8y C    24.2200  -23.1000
            7   C8y C    24.2200  -21.7000
            8   N4y N    23.1000  -21.0000
            9   C8y C    21.8400  -21.7000
            10  N4y N    21.8400  -23.1000
            11  C1y C    23.1000  -19.6000
            12  O5x O    25.4100  -21.0000
            13  O5x O    20.6500  -21.0000
            14  O5x O    24.2200  -27.3000
            15  C1a C    26.6700  -25.9000
            16  N1b N    26.6700  -23.1000
            17  C8y C    27.8600  -23.8000
            18  C8x C    27.8600  -25.1300
            19  C8x C    29.1200  -25.8300
            20  C8y C    30.3100  -25.1300
            21  C8x C    30.3100  -23.8000
            22  C8y C    29.1200  -23.1000
            23  X   F    29.1200  -21.7000
            24  X   I    31.5000  -25.8300
            25  C1a C    21.8400  -25.8300
            26  C8y C    20.6500  -23.8000
            27  C8x C    19.4600  -23.1000
            28  C8y C    18.2700  -23.8000
            29  C8x C    18.2700  -25.2000
            30  C8x C    19.4600  -25.8300
            31  C8x C    20.6500  -25.1300
            32  N1b N    17.0100  -23.1000
            33  C5a C    15.8200  -23.8000
            34  C1a C    14.6300  -23.1000
            35  O5a O    15.8200  -25.1300
            36  C1x C    23.8000  -18.4100
            37  C1x C    22.4000  -18.4100
            38  S4a S    35.9800  -24.3600
            39  C1a C    37.1924  -25.0600
            40  C1a C    34.7676  -25.0600
            41  O3c O    35.9800  -22.9600
BOND        44
            1     1   2 2
            2     2   3 1
            3     3   4 1
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     6   7 1
            8     7   8 1
            9     8   9 1
            10    9  10 1
            11    1  10 1
            12    8  11 1
            13    7  12 2
            14    9  13 2
            15    3  14 2
            16    4  15 1
            17    5  16 1
            18   16  17 1
            19   17  18 2
            20   18  19 1
            21   19  20 2
            22   20  21 1
            23   21  22 2
            24   17  22 1
            25   22  23 1
            26   20  24 1
            27    2  25 1
            28   10  26 1
            29   26  27 2
            30   27  28 1
            31   28  29 2
            32   29  30 1
            33   30  31 2
            34   26  31 1
            35   28  32 1
            36   32  33 1
            37   33  34 1
            38   33  35 2
            39   36  37 1
            40   37  11 1
            41   11  36 1
            42   38  39 1
            43   38  40 1
            44   38  41 2
///
